Biocon completes Rs. 4,150 crore equity fundraise through QIP
The proceeds from the ?IP will be primarily utilized to meet the cash consideration payable to Mylan Inc. (Viatris) for buying out its shareholding in Biocon Biologics Limited
The proceeds from the ?IP will be primarily utilized to meet the cash consideration payable to Mylan Inc. (Viatris) for buying out its shareholding in Biocon Biologics Limited
The feature will be available across all Max Healthcare facilities, offering patients consistent and convenient access to services nationwide
The findings, from the SPACE study, paved the way for FDA approval of AJOVY for pediatric patients aged 6-17 years weighing 45 kilograms
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
GRIN-NDD is one of the most complex neurodevelopmental disorders with limited treatment options today
Developed using STEERLife’s proprietary FragMelt continuous processing platform, the approval marks a major breakthrough in pharmaceutical manufacturing
Subscribe To Our Newsletter & Stay Updated